Literature DB >> 27400007

Salpingo-Oophorectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery.

Karl Jallad1, Lauren Siff, Tonya Thomas, Marie Fidela R Paraiso.   

Abstract

BACKGROUND: Vaginal hysterectomy is the preferred route of hysterectomy in benign gynecologic disease; however, a vaginal salpingo-oophorectomy can sometimes be technically challenging. Even the most skilled vaginal surgeon will occasionally have to convert to an abdominal approach to complete the procedure. TECHNIQUE: After a vaginal hysterectomy, if the surgeon is struggling to safely complete a salpingo-oophorectomy, a natural orifice transluminal endoscopic surgery (NOTES) approach could be considered. A single port is placed in the vagina and after achieving pneumoperitoneum, an endoscope is introduced to perform a survey of the pelvis and lower abdomen. The salpingo-oophorectomy can then be completed under direct visualization by using conventional laparoscopic instruments through the vaginal port. EXPERIENCE: Salpingo-oophorectomy was successfully completed in six unembalmed cadavers and in two live patients.
CONCLUSION: At the time of difficult vaginal salpingo-oophorectomy, the use of a NOTES approach could circumvent the need to convert to an abdominal route. It provides clear visualization of the entire pelvic and abdominal area and is technically feasible.

Entities:  

Mesh:

Year:  2016        PMID: 27400007     DOI: 10.1097/AOG.0000000000001513

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Hysterectomy by vaginal-assisted natural orifice transluminal endoscopic surgery: Initial experience with twelve cases.

Authors:  Cihan Kaya; İsmail Alay; Murat Ekin; Levent Yaşar
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-03-01

Review 2.  Artificial intelligence in reproductive medicine.

Authors:  Renjie Wang; Wei Pan; Lei Jin; Yuehan Li; Yudi Geng; Chun Gao; Gang Chen; Hui Wang; Ding Ma; Shujie Liao
Journal:  Reproduction       Date:  2019-10       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.